Zai Lab Q3 revenue falls to $108.2 million; net loss widens to $46.1 million
Zai Lab reported third-quarter 2026 total revenue of $108.2 million, down from $116.1 million a year earlier, and a net loss of $46.1 million, or $0.04 per ordinary share, compared with $36.0 million, or $0.03, in the prior-year quarter. The company attributed the larger loss mainly to $13.6 million in inventory write-downs and said it completed a private placement with gross proceeds of about $250.0 million in October 2026.
Key points
- Total revenue was $108.2 million, versus $116.1 million in Q3 2025; net product revenue rose 2% from Q2 2026.
- Net loss was $46.1 million ($0.04 per share), versus $36.0 million ($0.03 per share) a year earlier, mainly due to $13.6 million in inventory write-downs.
- Private placement of 11,340,000 ADSs at $22.04 each closed October 27, 2026, with net proceeds of about $241.2 million.
- Cash, restricted cash and short-term investments totaled $659.7 million at September 30, 2026, down from $717.5 million at June 30, 2026.
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.